Clinical Trial Update: Phosphate Binder-combination Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis [Phase 3]

View source ↗

Summary

Phase 3 trial update for KHK7791 phosphate binder combo in hyperphosphatemia patients on hemodialysis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperphosphatemia

Drugs mentioned

• KHK7791

Snippet

Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Hyperphosphatemia | Phase 3 | Status: COMPLETED